Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Presentation TCT 2019

Bioresorbable Scaffolds: Global Development Pipeline

Presenter: Yoshinobu Onuma

September 28, 2019

Presentation TCT 2019

BRS Use in Primary PCI: Rational and Emerging Clinical Data

Presenter: Manel Sabate

September 28, 2019

Presentation TCT 2019

The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval

Presenter: Andrew Farb

September 28, 2019

Presentation TCT 2019

Late Benefits From BVS: Theory and Evidence

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

The Absorb BVS Epilogue: How Did We Miss the Safety Signals?

Presenter: Renu Virmani

September 28, 2019

Presentation TCT 2019

Sirolimus-Coated Balloon Therapy: State of Development

Presenter: Stefan Verheye

September 28, 2019

Presentation TCT 2019

DAPT After PCI With DCB: Current Guidelines and Special Considerations

Presenter: Marco Valgimigli

September 28, 2019

Presentation TCT 2019

Emerging Data on Drug-Coated Balloon Use in the High Bleeding or High Thrombotic Risk Patient

Presenter: Bruno Scheller

September 28, 2019

Presentation TCT 2019

Drug-Coated Balloons in De Novo Lesions: Case Vignettes From Asia

Presenter: Paul Ong

September 28, 2019

Presentation TCT 2019

Drug-Coated Balloons in De Novo Lesions: Case Vignettes From Europe

Presenter: Bernardo Cortese

September 28, 2019

Presentation TCT 2019

Drug-Coated Balloons for Small Vessels: Latest Trial Evidence

Presenter: Bernardo Cortese

September 28, 2019

Presentation TCT 2019

Tips and Tricks for DCB Use: Optimal Technique Is Still Important

Presenter: Azeem Latib

September 28, 2019

Presentation TCT 2019

Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration

Presenter: Robert Byrne

September 28, 2019

Presentation TCT 2019

TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted With Improved Technique: Two-year Results From the ABSORB IV Randomized Trial

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation TCT 2019

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Presenter: Run-Lin Gao

September 25, 2019

Presentation TCT 2019

TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes

Presenter: Alexandre Abizaid

September 25, 2019

Presentation TCT 2019

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Stefan Verheye

September 25, 2019

Presentation TCT 2019

TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA

Presenter: Takahiro Jimba

September 25, 2019

Presentation TCT 2019

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Presenter: Jens Wiebe

September 25, 2019

Advertisement

Bioresorbable Scaffolds: Global Development Pipeline

BRS Use in Primary PCI: Rational and Emerging Clinical Data

The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval

Late Benefits From BVS: Theory and Evidence

The Absorb BVS Epilogue: How Did We Miss the Safety Signals?

Sirolimus-Coated Balloon Therapy: State of Development

DAPT After PCI With DCB: Current Guidelines and Special Considerations

Emerging Data on Drug-Coated Balloon Use in the High Bleeding or High Thrombotic Risk Patient

Drug-Coated Balloons in De Novo Lesions: Case Vignettes From Asia

Drug-Coated Balloons in De Novo Lesions: Case Vignettes From Europe

Drug-Coated Balloons for Small Vessels: Latest Trial Evidence

Tips and Tricks for DCB Use: Optimal Technique Is Still Important

Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration

TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted With Improved Technique: Two-year Results From the ABSORB IV Randomized Trial

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content